Investing First patient dosed in Phase IIb imaging for Brain Mets by April 28, 2025 April 28, 2025 Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com previous post Binding Commitments Received for A$1.0 Million under Convertible Note Placement next post S&P 500 Rises from Bearish to Neutral, But Will It Last? You may also like What is the VIX Index? April 29, 2025 Trump Takes Aim at China with Deep-Sea Mining... April 29, 2025 Are We in a Recession? Predictions, Signs and... April 29, 2025 FPX Nickel Announces Board and Management Changes April 29, 2025 Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its... April 29, 2025 Stagflation Looms: Why Economists Are Warning of a... April 28, 2025 Binding Commitments Received for A$1.0 Million under Convertible... April 28, 2025 Heliostar Delivers Strong First Quarter 2025 Results April 28, 2025 Silver Crown Royalties Announces Closing of Final Tranche... April 28, 2025 Tech 5: Major Players Release Latest Results, Google’s... April 27, 2025